AOD vs ASST

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 5/9, indicating stable financial health, while the absence of an Altman Z-Score limits distress risk assessment. The stock trades significantly below its growth-based intrinsic value of $45.73 at a current price of $10.00, suggesting deep value potential, yet the weak technical trend (10/100) and low liquidity metrics raise caution. Strong profitability metrics like a 227.23% profit margin and 96.40% YoY earnings growth are counterbalanced by a concerning current ratio of 0.75 and minimal insider activity. The 11.58% dividend yield is attractive but faces sustainability questions due to a high 74.52% payout ratio and weak short-term liquidity.

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm solvency, raising uncertainty. Despite a strong revenue growth of 56.80% YoY and a low Price/Book of 0.74 suggesting possible value, extreme negative operating margins (-3064.29%) and a sky-high Price/Sales ratio of 197.00 signal severe profitability and valuation concerns. The stock has lost over 95% of its value in the past five years, with a current technical trend scoring 0/100, reflecting deep investor skepticism. While the balance sheet shows no debt and high liquidity ratios, these positives are overshadowed by absent profitability, lack of earnings, and minimal analyst coverage.